Profile picture

Doctor Markus Riederer

Idorsia Pharmaceuticals Ltd., Allschwil (Switzerland)
Follow
Logo ESC

Contributor content

Selatogrel, the reversible and specific P2Y12 receptor antagonist, does not interfere with haemostasis
Presentation
Selatogrel, the reversible and specific P2Y12 receptor antagonist, does not interfere with haemostasis

ESC 365 is supported by